1887

Abstract

(MP) is the most common atypical pathogen that causes respiratory infections in children. Such infections are typically treated by macrolide antibiotics, but the duration of treatment is variable. In this study, we used nested PCR to amplify the 16S rDNA (16S rRNA gene) of MP at different stages of MP pneumonia (MPP) in 100 children who were admitted for lower respiratory tract infections and diagnosed with MPP. Our results indicate that the median duration of MP-DNA positivity was 5 weeks, and 78 % of cases tested positive for 3–6 weeks. Patients with severe disease were positive for MP-DNA for a significantly longer time (median of 6 weeks) than those with mild disease (median of 4 weeks). Thirty-one patients with severe disease who received intravenous immunoglobulin were MP-DNA positive for significantly less time than patients with severe disease who did not receive this treatment. The duration of MP-DNA positivity was prolonged when MP antibody levels were high and treatment was started at a later stage. Therefore, nested PCR can be used for early diagnosis of MP and the duration of MP-DNA reflects the clinical stage of MPP. Early treatment of MPP and the administration of intravenous immunoglobulin during the acute phase of severe MPP shorten the duration of MP-DNA positivity.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.030098-0
2012-03-01
2020-01-29
Loading full text...

Full text loading...

/deliver/fulltext/jmm/61/3/426.html?itemId=/content/journal/jmm/10.1099/jmm.0.030098-0&mimeType=html&fmt=ahah

References

  1. Beersma M. F., Dirven K., van Dam A. P., Templeton K. E., Claas E. C., Goossens H.. ( 2005;). Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma pneumoniae-specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the “gold standard”. . J Clin Microbiol 43:, 2277–2285. [CrossRef][PubMed]
    [Google Scholar]
  2. Daxboeck F., Krause R., Wenisch C.. ( 2003;). Laboratory diagnosis of Mycoplasma pneumoniae infection. . Clin Microbiol Infect 9:, 263–273. [CrossRef][PubMed]
    [Google Scholar]
  3. Dumke R., Jacobs E.. ( 2009;). Comparison of commercial and in-house real-time PCR assays used for detection of Mycoplasma pneumoniae.. J Clin Microbiol 47:, 441–444. [CrossRef][PubMed]
    [Google Scholar]
  4. Gullsby K., Storm M., Bondeson K.. ( 2008;). Simultaneous detection of Chlamydophila pneumoniae and Mycoplasma pneumoniae by use of molecular beacons in a duplex real-time PCR. . J Clin Microbiol 46:, 727–731. [CrossRef][PubMed]
    [Google Scholar]
  5. Hou A. C., Liu Y. H., Xin D. L., Li J., Geng B., Cui H., Zhang S. L., Xu S. Z., Zhao G. C.. ( 2002;). Nasopharyngeal carriage status of common pathogenic microorganisms in healthy children and its clinical significance. . Zhonghua Er Ke Za Zhi 40:, 45–49 (in Chinese).
    [Google Scholar]
  6. Lee K. Y.. ( 2008;). Pediatric respiratory infections by Mycoplasma pneumoniae.. Expert Rev Anti Infect Ther 6:, 509–521. [CrossRef][PubMed]
    [Google Scholar]
  7. McDonough E. A., Barrozo C. P., Russell K. L., Metzgar D.. ( 2005;). A multiplex PCR for detection of Mycoplasma pneumoniae, Chlamydophila pneumoniae, Legionella pneumophila, and Bordetella pertussis in clinical specimens. . Mol Cell Probes 19:, 314–322. [CrossRef][PubMed]
    [Google Scholar]
  8. Negi V. S., Elluru S., Sibéril S., Graff-Dubois S., Mouthon L., Kazatchkine M. D., Lacroix-Desmazes S., Bayry J., Kaveri S. V.. ( 2007;). Intravenous immunoglobulin: an update on the clinical use and mechanisms of action. . J Clin Immunol 27:, 233–245. [CrossRef][PubMed]
    [Google Scholar]
  9. Nilsson A. C., Björkman P., Persson K.. ( 2008;). Polymerase chain reaction is superior to serology for the diagnosis of acute Mycoplasma pneumoniae infection and reveals a high rate of persistent infection. . BMC Microbiol 8:, 93. [CrossRef][PubMed]
    [Google Scholar]
  10. Nour M., Trabelsi A., Maatouk N., Hammami M.. ( 2005;). Amplification of P1 and 16S rRNA genes by nested PCR for detection of Mycoplasma pneumoniae in paediatric patients. . Pathol Biol (Paris) 53:, 9–14. [CrossRef][PubMed]
    [Google Scholar]
  11. Okazaki N., Ohya H., Sasaki T.. ( 2007;). Mycoplasma pneumoniae isolated from patients with respiratory infection in Kanagawa Prefecture in 1976–2006: emergence of macrolide-resistant strains. . Jpn J Infect Dis 60:, 325–326.[PubMed]
    [Google Scholar]
  12. Sung H., Kang S. H., Bae Y. J., Hong J. T., Chung Y. B., Lee C. K., Song S.. ( 2006;). PCR-based detection of Mycoplasma species. . J Microbiol 44:, 42–49.[PubMed]
    [Google Scholar]
  13. Waites K. B., Talkington D. F.. ( 2004;). Mycoplasma pneumoniae and its role as a human pathogen. . Clin Microbiol Rev 17:, 697–728. [CrossRef][PubMed]
    [Google Scholar]
  14. Waites K. B., Balish M. F., Atkinson T. P.. ( 2008;). New insights into the pathogenesis and detection of Mycoplasma pneumoniae infections. . Future Microbiol 3:, 635–648. [CrossRef][PubMed]
    [Google Scholar]
  15. Youn Y. S., Lee K. Y., Hwang J. Y., Rhim J. W., Kang J. H., Lee J. S., Kim J. C.. ( 2010;). Difference of clinical features in childhood Mycoplasma pneumoniae pneumonia. . BMC Pediatr 10:, 48. [CrossRef][PubMed]
    [Google Scholar]
  16. Yuan Z., Xue X.. ( 2002;). In Mycoplasma pneumoniae Encephalitis. Review of Diagnosis and Treatment of Critically Ill Pediatric Patients and Difficult Cases, pp. 256–257. Shenyang:: People's Medical Publishing House;.
    [Google Scholar]
  17. Zhang Z. R.. ( 2004;). Clinical Microbiology and Microbiological Examination, , 3rd edn.. Beijing:: People's Medical Publishing House;.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.030098-0
Loading
/content/journal/jmm/10.1099/jmm.0.030098-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error